Dr. Peng Zhao's lab at the University of Texas Health Science Center focuses on understanding how liver injury occurs in nonalcoholic steatohepatitis (NASH), a serious liver disease that can lead to cirrhosis and liver cancer. By exploring the role of specific proteins and cellular processes, the lab aims to identify new therapeutic approaches to treat NASH and improve liver health. This research is essential for developing effective strategies to combat this growing public health issue.